ATCHISON, Kan., Oct. 19, 2017 -- MGP Ingredients, Inc. (Nasdaq:MGPI), a leading supplier of premium distilled spirits and specialty wheat proteins and starches, today announced that it will hold a conference call/webcast to discuss results for the third quarter ended Sept. 30, 2017, on Thursday, November 2, at 10 a.m. ET. The company expects to release its financial results before the market opens that morning.
Management on the call will include Gus Griffin, president and CEO, and Tom Pigott, vice president of finance and CFO.
The call/webcast will be available via:
| Webcast: | ir.mgpingredients.com on the Presentations & Webcasts page | |
| Conference Call: | 844-308-6398 (domestic) or 412-717-9605 (international) |
A replay will be available on the MGP Ingredients website after the call concludes.
About MGP Ingredients, Inc.
MGP is a leading producer and supplier of premium distilled spirits and specialty wheat proteins and starches. Distilled spirits include premium bourbon and rye whiskeys, gins and vodkas, which are carefully crafted through a combination of art and science and backed by over 150 years of experience. The company’s proteins and starches are created in the same manner and provide a host of functional, nutritional and sensory benefits for a wide range of food products. MGP additionally is a top producer of high quality industrial alcohol for use in both food and non-food applications. The company is headquartered in Atchison, Kansas, where distilled alcohol products and food ingredients are produced. Premium spirits are also distilled and matured at the company facility in Lawrenceburg, Indiana. For more information, visit mgpingredients.com.
For More Information
Investors & Analysts:
Mike Houston
616-233-0500 or [email protected]
Media:
Greg Manis
913-360-5440 or [email protected]


Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 



